A carregar...

Current Progress in CAR-T Cell Therapy for Hematological Malignancies

Immunotherapies, such as monoclonal antibody therapy and checkpoint inhibitor therapy, have shown inspiring clinical effects for the treatment of cancer. Chimeric antigen receptor T (CAR-T) cells therapy was an efficacious therapeutic approach treating hematological malignancies and encouraging resu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Han, Donglei, Xu, Zenghui, Zhuang, Yuan, Ye, Zhenlong, Qian, Qijun
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738987/
https://ncbi.nlm.nih.gov/pubmed/33391429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.48976
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!